<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37277786</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Burden of long COVID among adults experiencing sheltered homelessness: a longitudinal cohort study in King County, WA between September 2020-April 2022.</ArticleTitle><Pagination><StartPage>1079</StartPage><MedlinePgn>1079</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1079</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-16026-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">People experiencing homelessness (PEH) are at increased risk for acquiring SARS-CoV-2, but the burden of long COVID in this population is unknown.</AbstractText><AbstractText Label="METHODS">We conducted a matched prospective cohort study to assess the prevalence, characteristics, and impact of long COVID among sheltered PEH in Seattle, WA between September 2020-April 2022. Adults&#x2009;&#x2265;&#x2009;18&#xa0;years, residing across nine homeless shelters with active respiratory virus surveillance, were eligible to complete in-person baseline surveys and interval follow-up phone surveys. We included a subset of 22 COVID-19-positive cases who tested positive or inconclusive for SARS-CoV-2 and 44 COVID-19-negative controls who tested negative for SARS-CoV-2, frequency matched on age and sex. Among controls, 22 were positive and 22 were negative for one of 27 other respiratory virus pathogens. To assess the impact of COVID-19 on the risk of symptom presence at follow-up (day 30-225 post-enrollment test), we performed log-linear regression with robust standard errors, adjusting for confounding by shelter site and demographic variables determined a priori.</AbstractText><AbstractText Label="RESULTS">Of 53 eligible COVID-19 cases, 22 (42%) completed&#x2009;&#x2265;&#x2009;1 follow-up survey. While five (23%) cases reported&#x2009;&#x2265;&#x2009;1 symptom at baseline, this increased to 77% (10/13) between day 30-59 and 33% (4/12) day 90&#x2009;+&#x2009;. The most commonly reported symptoms day 30&#x2009;+&#x2009;were fatigue (27%) and rhinorrhea (27%), with 8 (36%) reporting symptoms that interfered with or prevented daily activities. Four (33%) symptomatic cases reported receiving medical care outside of a medical provider at an isolation facility. Of 44 controls, 12 (27%) reported any symptoms day 90&#x2009;+&#x2009;. Risk of any symptoms at follow-up was 5.4 times higher among COVID-19 cases compared to controls (95% CI: 2.7-10.5).</AbstractText><AbstractText Label="CONCLUSIONS">Shelter residents reported a high prevalence of symptoms 30&#x2009;+&#x2009;days after their SARS-CoV-2 detection, though few accessed medical care for persistent illness. The impact of COVID-19 extends beyond acute illness and may exacerbate existing challenges that marginalized populations face in maintaining their health and wellbeing.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Sarah N</ForeName><Initials>SN</Initials><Identifier Source="ORCID">0000-0002-2447-0504</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, WA, Seattle, USA. sarahcox@uw.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA. sarahcox@uw.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Emily M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado, Denver, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Julia H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, WA, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health - Seattle &amp; King County, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wasse</LastName><ForeName>Jessica K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Public Health - Seattle &amp; King County, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carone</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fred Hutchinson Cancer Center, Vaccine and Infectious Disease Division, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Helen Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, WA, Seattle, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, University of Washington, Seattle, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 AI007044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006703" MajorTopicYN="Y">Ill-Housed Persons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Homelessness</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 conditions</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. Dr. Chu reports consulting with The Bill and Melinda Gates Foundation, Ellume, Abbvie, Pfizer, Medscape, and Vindico. She has received research funding from The Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Defense Advanced Research Projects Agency, Gates Ventures, National Institutes of Health, Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>6</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37277786</ArticleId><ArticleId IdType="pmc">PMC10241609</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-16026-7</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-16026-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;14. Available from: https://www.nature.com/articles/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, Lowe DJ, McAuley A, Winter AJ, Mills NL, Black C, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat Commun. 2022;13(1):5663. Available from: https://www.nature.com/articles/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol . 2022;23(2):194&#x2013;202. Available from: https://www.nature.com/articles/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Post-COVID Conditions [Internet]. Centers for Disease Control and Prevention. 2022 [cited 2022 Aug 24]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Lond). 2021;21(1):e63&#x2013;7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850225/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604. Available from: https://jamanetwork.com/journals/jama/fullarticle/2797443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, Blumberg L, Mayet N, Cohen C, et al. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. The Lancet Global Health. 2022;10(9):e1247&#x2013;56. Available from: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(22)00286-8/fulltext.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobolowsky FA, Gonzales E, Self JL, Rao CY, Keating R, Marx GE, et al. COVID-19 Outbreak Among Three Affiliated Homeless Service Sites - King County, Washington, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(17):523&#x2013;526. doi: 10.15585/mmwr.mm6917e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6917e2</ArticleId><ArticleId IdType="pmc">PMC7206987</ArticleId><ArticleId IdType="pubmed">32352954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosites E, Parker EM, Clarke KEN, Gaeta JM, Baggett TP, Imbert E, et al. Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters - Four U.S. Cities, March 27-April 15, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(17):521&#x2013;2. doi: 10.15585/mmwr.mm6917e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6917e1</ArticleId><ArticleId IdType="pmc">PMC7206983</ArticleId><ArticleId IdType="pubmed">32352957</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett TP, Keyes H, Sporn N, Gaeta JM. Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston. JAMA. 2020;323(21):2191&#x2013;2192. doi: 10.1001/jama.2020.6887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6887</ArticleId><ArticleId IdType="pmc">PMC7186911</ArticleId><ArticleId IdType="pubmed">32338732</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawley C, Kanzaria HK, Zevin B, Doran KM, Kushel M, Raven MC. Mortality Among People Experiencing Homelessness in San Francisco During the COVID-19 Pandemic. JAMA Network Open. 2022;5(3):e221870. doi: 10.1001/jamanetworkopen.2022.1870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.1870</ArticleId><ArticleId IdType="pmc">PMC8914573</ArticleId><ArticleId IdType="pubmed">35267030</ArticleId></ArticleIdList></Reference><Reference><Citation>Imbert E, Kinley PM, Scarborough A, Cawley C, Sankaran M, Cox SN, et al. Coronavirus Disease 2019 Outbreak in a San Francisco Homeless Shelter. Clin Infect Dis. 2021;73(2):324&#x2013;327. doi: 10.1093/cid/ciaa1071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1071</ArticleId><ArticleId IdType="pmc">PMC7454344</ArticleId><ArticleId IdType="pubmed">32744615</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet. 2018;391(10117):241&#x2013;250. doi: 10.1016/S0140-6736(17)31869-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31869-X</ArticleId><ArticleId IdType="pmc">PMC5803132</ArticleId><ArticleId IdType="pubmed">29137869</ArticleId></ArticleIdList></Reference><Reference><Citation>Perri M, Dosani N, Hwang SW. COVID-19 and people experiencing homelessness: challenges and mitigation strategies. CMAJ. 2020;192(26):E716&#x2013;9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828890/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7828890</ArticleId><ArticleId IdType="pubmed">32601252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578. doi: 10.7326/M20-5661.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020;20(1):1144. doi: 10.1186/s12913-020-06001-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;2020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott E, Cox S, Rogers J, Wasse J, Chu H. 344. Prevalence and Impact of Post-Acute Sequelae of COVID-19 Among People Experiencing Homelessness in King County, WA Between September 2020 - May 2021. Open Forum Infect Dis. 2021;8(Supplement_1):S275&#x2013;76. 10.1093/ofid/ofab466.545.</Citation></Reference><Reference><Citation>Chu HY, Boeckh M, Englund JA, Famulare M, Lutz B, Nickerson DA, et al. The Seattle Flu Study: a multiarm community-based prospective study protocol for assessing influenza prevalence, transmission and genomic epidemiology. BMJ Open. 2020;10(10):e037295. doi: 10.1136/bmjopen-2020-037295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-037295</ArticleId><ArticleId IdType="pmc">PMC7542952</ArticleId><ArticleId IdType="pubmed">33033018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JH, Link AC, McCulloch D, Brandstetter E, Newman KL, Jackson ML, et al. Characteristics of COVID-19 in Homeless Shelters : A Community-Based Surveillance Study. Ann Intern Med. 2021;174(1):42&#x2013;49. doi: 10.7326/M20-3799.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3799</ArticleId><ArticleId IdType="pmc">PMC7517131</ArticleId><ArticleId IdType="pubmed">32931328</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. Health-Related Quality of Life (HRQOL): Measuring Healthy Days-Population Assessment of Health-Related Quality of Life. 2021 [cited 2022 May 4]. Available from: https://www.cdc.gov/hrqol/pdfs/mhd.pdf.</Citation></Reference><Reference><Citation>Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun. 2022;13(1):1812. Available from: https://www.nature.com/articles/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend JP, Lamb AD, Hassler HB, Sah P, Nishio AA, Nguyen C, et al. Projecting the seasonality of endemic COVID-19. medRxiv; 2022 [cited 2022 Aug 24]. p. 2022.01.26.22269905. Available from: https://www.medrxiv.org/content/10.1101/2022.01.26.22269905v1.</Citation></Reference><Reference><Citation>Lindsay L, Secrest MH, Rizzo S, Keebler DS, Yang F, Tsai L. Factors associated with COVID-19 viral and antibody test positivity and assessment of test concordance: a retrospective cohort study using electronic health records from the USA. BMJ Open. 2022;11(10):e051707. Available from: https://bmjopen.bmj.com/content/11/10/e051707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8488284</ArticleId><ArticleId IdType="pubmed">34598988</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Cases, Data, and Surveillance [Internet]. Centers for Disease Control and Prevention. 2020 [cited 2022 Aug 24]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html.</Citation></Reference><Reference><Citation>Jones J, Sullivan PS, Sanchez TH, Guest JL, Hall EW, Luisi N, et al. Similarities and Differences in COVID-19 Awareness, Concern, and Symptoms by Race and Ethnicity in the United States: Cross-Sectional Survey. J Med Internet Res. 2020;22(7):e20001. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357692/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7357692</ArticleId><ArticleId IdType="pubmed">32614778</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst JC, Laditka SB, Moore CG, Harun N, Powell MP. Race and ethnicity differences in reporting of depressive symptoms. Adm Policy Ment Health. 2007;34(6):519&#x2013;529. doi: 10.1007/s10488-007-0136-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10488-007-0136-9</ArticleId><ArticleId IdType="pubmed">17849182</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1957. Available from: https://www.nature.com/articles/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Galal I, Hussein AARM, Amin MT, Saad MM, Zayan HEE, Abdelsayed MZ, et al. Determinants of persistent post-COVID-19 symptoms: value of a novel COVID-19 symptom score. Egypt J Bronchol. 2021;15(1):10. doi: 10.1186/s43168-020-00049-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43168-020-00049-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho WKT, Hwang DG. Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area [published online ahead of print, 2022 Jul 19]. J Racial Ethn Health Disparities. 2022. 10.1007/s40615-022-01351-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">35852709</ArticleId></ArticleIdList></Reference><Reference><Citation>van Westen-Lagerweij NA, Meijer E, Meeuwsen EG, Chavannes NH, Willemsen MC, Croes EA. Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth. npj Prim Care Respir Med. 2021;31(1):1&#x2013;3. Available from: https://www.nature.com/articles/s41533-021-00223-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910565</ArticleId><ArticleId IdType="pubmed">33637750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J, Cox S, Link A, Nwanne G, Han P, Pfau B, et al. Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study. 10.1101/2023.05.25.23290471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10540173</ArticleId><ArticleId IdType="pubmed">37424310</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiran T, Craig-Neil A, Das P, Lockwood J, Wang R, Nathanielsz N, et al. Association of Homelessness with COVID-19 Positivity among Individuals Visiting a Testing Centre: A Cross-Sectional Study. Healthc Policy. 2022;17(3):34&#x2013;41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935920/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935920</ArticleId><ArticleId IdType="pubmed">35319442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn BM. Homeless Shelters Face High COVID-19 Risks. JAMA. 2020;323(22):2240.</Citation><ArticleIdList><ArticleId IdType="pubmed">32515823</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung CS, Ho MM, Kiss A, Gundlapalli AV, Hwang SW. Homelessness and the response to emerging infectious disease outbreaks: lessons from SARS. J Urban Health. 2008;85(3):402&#x2013;410. doi: 10.1007/s11524-008-9270-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11524-008-9270-2</ArticleId><ArticleId IdType="pmc">PMC2329752</ArticleId><ArticleId IdType="pubmed">18347991</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J, Wilson M. COVID-19: a potential public health problem for homeless populations. Lancet Public Health. 2020;5(4):e186&#x2013;e187. doi: 10.1016/S2468-2667(20)30053-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30053-0</ArticleId><ArticleId IdType="pmc">PMC7104053</ArticleId><ArticleId IdType="pubmed">32171054</ArticleId></ArticleIdList></Reference><Reference><Citation>Patanwala M, Tieu L, Ponath C, Guzman D, Ritchie CS, Kushel M. Physical, Psychological, Social, and Existential Symptoms in Older Homeless-Experienced Adults: An Observational Study of the Hope Home Cohort. J Gen Intern Med. 2018;33(5):635&#x2013;43. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910332/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910332</ArticleId><ArticleId IdType="pubmed">29185174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristjansdottir OB, Stenberg U, Mirkovic J, Krogseth T, Ljos&#xe5; TM, Stange KC, et al. Personal strengths reported by people with chronic illness: A qualitative study. Health Expectations. 2018;21(4):787&#x2013;95. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/hex.12674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6117496</ArticleId><ArticleId IdType="pubmed">29478260</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort. J Gen Intern Med. 2022;37(8):1988&#x2013;95. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989256/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Michigan. Long COVID: Women, Hispanics and lower-income Michiganders hit hardest. University of Michigan News. 2022 [cited 2022 Aug 25]. Available from: https://news.umich.edu/long-covid-women-hispanics-and-lower-income-michiganders-hit-hardest/.</Citation></Reference><Reference><Citation>Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. Cham: Springer International Publishing; 2015. (Springer Series in Statistics). Available from: http://link.springer.com/10.1007/978-3-319-19425-7.</Citation></Reference><Reference><Citation>Stone CS, Koo C. Additive splines in statistics. In Proceedings of the Statistical Computing Section ASA, Proceedings of the American Statistical Association. 1985 [cited 2022 Aug 26];45&#x2013;8. Available from: https://paperzz.com/doc/6912999/additive-splines-in-statistics.</Citation></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Louge J, Franko N, McCulloch D, McDonald D, Magedson A, Wolf C, et al. Sequelae in Adults at 6 Months After COVID-19 Infection | Infectious Diseases | JAMA Network Open | JAMA Network. [cited 2022 Aug 25]; Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett TP, Liauw SS, Hwang SW. Cardiovascular Disease and Homelessness. J Am Coll Cardiol. 2018;71(22):2585&#x2013;2597. doi: 10.1016/j.jacc.2018.02.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.02.077</ArticleId><ArticleId IdType="pubmed">29852981</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggett TP, O&#x2019;Connell JJ, Singer DE, Rigotti NA. The unmet health care needs of homeless adults: a national study. Am J Public Health. 2010;100(7):1326&#x2013;1333. doi: 10.2105/AJPH.2009.180109.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2009.180109</ArticleId><ArticleId IdType="pmc">PMC2882397</ArticleId><ArticleId IdType="pubmed">20466953</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutchmun W, Gach J, Borup C, Froeschl G. Chronic diseases and multi-morbidity in persons experiencing homelessness: results from a cross-sectional study conducted at three humanitarian clinics in Germany in 2020. BMC Public Health. 2022;22(1):1597. doi: 10.1186/s12889-022-14023-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-022-14023-w</ArticleId><ArticleId IdType="pmc">PMC9395771</ArticleId><ArticleId IdType="pubmed">35996145</ArticleId></ArticleIdList></Reference><Reference><Citation>Purkey E, MacKenzie M. Experience of healthcare among the homeless and vulnerably housed a qualitative study: opportunities for equity-oriented health care. Int J Equity Health. 2019;18(1):101. doi: 10.1186/s12939-019-1004-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12939-019-1004-4</ArticleId><ArticleId IdType="pmc">PMC6604349</ArticleId><ArticleId IdType="pubmed">31262310</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins DC. Experiences of homeless people in the health care delivery system: a descriptive phenomenological study. Public Health Nurs. 2008;25(5):420&#x2013;430. doi: 10.1111/j.1525-1446.2008.00726.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1446.2008.00726.x</ArticleId><ArticleId IdType="pubmed">18816359</ArticleId></ArticleIdList></Reference><Reference><Citation>Taghrir MH, Akbarialiabad H, Abdollahi A, Ghahramani N, Bastani B, Paydar S, et al. Inequity and disparities mar existing global research evidence on Long COVID. Glob Health Promot. 2022;12:17579759221113276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10076956</ArticleId><ArticleId IdType="pubmed">35962520</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression Methods in Biostatistics. Boston, MA: Springer US; 2012 [cited 2022 Aug 25]. (Statistics for Biology and Health). Available from: http://link.springer.com/10.1007/978-1-4614-1353-0.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>